Feasibility and Accuracy of Automated Software for Transthoracic Three-Dimensional Left Ventricular Volume and Function Analysis: Comparisons with Two-Dimensional Echocardiography, Three-Dimensional Transthoracic Manual Method, and Cardiac Magnetic Resonance Imaging

Tamborini, Gloria; Piazzese, Concetta; Lang, Roberto M.; Muratori, Manuela; Chiorino, Elisa; Mapelli, Massimo; Fusini, Laura; Ali, Sarah; Gripari, Paola; Pontone, Gianluca; Andreini, Daniele; Pepi, Mauro

doi:10.1016/j.echo.2017.06.026

Cited by 78 publications

(61 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…According to recent opinions, 3D echocardiography may be preferable over 2D echocardiography (2DE) to assess LVEF in cancer patients, because of its low analysis time, higher reproducibility, and higher feasibility. 62,63 3D echocardiography has demonstrated to outperform 2DE in detecting LVEF changes in cancer patients. 64 Global longitudinal strain has arisen as another parameter to characterize myocardial tissue in the past years.…”

Section: Diagnosis and Preventionmentioning

confidence: 99%

Recent advances in cardio‐oncology: a report from the ‘Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019’

et al. 2019

View full text Add to dashboard Cite

While anti-cancer therapies, including chemotherapy, immunotherapy, radiotherapy, and targeted therapy, are constantly advancing, cardiovascular toxicity has become a major challenge for cardiologists and oncologists. This has led to an increasing demand of cardio-oncology units in Europe and a growing interest of clinicians and researchers. The Heart Failure 2019 meeting of the Heart Failure Association of the European Society of Cardiology in Athens has therefore created a scientific programme that included four dedicated sessions on the topic along with several additional lectures. The major points that were discussed at the congress included the implementation and delivery of a cardio-oncology service, the collaboration among cardio-oncology experts, and the risk stratification, prevention, and early recognition of cardiotoxicity. Furthermore, sessions addressed the numerous different anti-cancer therapies associated with cardiotoxic effects and provided guidance on how to treat cancer patients who develop cardiovascular disease before, during, and after treatment.

show abstract

Section: Diagnosis and Preventionmentioning

confidence: 99%

Recent advances in cardio‐oncology: a report from the ‘Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019’

et al. 2019

View full text Add to dashboard Cite

show abstract

“…There was a minimal bias between LA EF estimates using 3D TTE and CMR, with a modest correlation between the two measurements ( Figure 4C; Table 2). It has been shown that 3D TTE with fully automated quantification software is rapid (with a processing time of~30 seconds 14 ) and highly feasible. The automated analysis of left-heart chambers was found to be suitable for routine use in two-thirds of 300 nonselected consecutive patients seen in a busy clinical laboratory, with adequate image quality.…”

Section: D Derived La Parametersmentioning

confidence: 99%

Performance of a new fully automated transthoracic three‐dimensional echocardiographic software for quantification of left cardiac chamber size and function: Comparison with 3 Tesla cardiac magnetic resonance

Lévy

Iacuzio

Schouver

et al. 2019

J of Clinical Ultrasound

View full text Add to dashboard Cite

Purpose To evaluate the accuracy and reproducibility of a new fully automated fast three‐dimensional (3D) transthoracic echocardiography (TTE) software for the simultaneous assessment of left atrial (LA) volumes and LA ejection fraction (EF), left ventricular (LV) volumes, LV mass, and LVEF, and to compare the results obtained with a cardiac magnetic resonance (CMR) reference. Methods We included retrospectively 56 patients (46 men; mean age 63 ± 13 years) in sinus rhythm who had had comprehensive 3D TTE and CMR examinations within 24 hours. Results Despite a slight underestimation of LV and LA volumes, LVEF and LAEF were similar using CMR or 3DTTE (58% ± 16% vs 58% ± 12%; P = .65 and 45% ± 14% vs 46% ± 15%; P = .38, respectively) in the total population. Despite significant correlation between TTE and CMR measurements (r = 0.78; P < .001), 3D TTE underestimated LV mass (bias = −27 ± 35 g). Conclusion 3D TTE using a new‐generation fully automated software is a fast and reproducible imaging modality for simultaneous extensive quantification of left heart chambers size and function in routine practice. Potential underestimation of LA volume and LV mass, and of LVEF in patients with LVEF <50%, should be taken into consideration.

show abstract

“…As you have mentioned in your letter, our methodology was not constructed in a fashion to look at validity; to assess this, we would have needed to have cardiac MR as comparison for cardiac volumes and ejection fraction. 2 Therefore, we have chosen to edit the title of our manuscript and replace the term Validity with Reproducibility.…”

Section: Reproducibility Of Automated Measurement Of Left Ventricularmentioning

confidence: 99%

Reproducibility of automated measurement of left ventricular volumes and ejection fraction using the Philips EPIQ system

et al. 2018

View full text Add to dashboard Cite

Feasibility and Accuracy of Automated Software for Transthoracic Three-Dimensional Left Ventricular Volume and Function Analysis: Comparisons with Two-Dimensional Echocardiography, Three-Dimensional Transthoracic Manual Method, and Cardiac Magnetic Resonance Imaging

Cited by 78 publications

References 24 publications

Recent advances in cardio‐oncology: a report from the ‘Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019’

Recent advances in cardio‐oncology: a report from the ‘Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019’

Performance of a new fully automated transthoracic three‐dimensional echocardiographic software for quantification of left cardiac chamber size and function: Comparison with 3 Tesla cardiac magnetic resonance

Reproducibility of automated measurement of left ventricular volumes and ejection fraction using the Philips EPIQ system

Contact Info

Product

Resources

About